Vés al contingut

Letermovir (LMV) prophylaxis in CMV-seronegative Allogeneic Stem Cell Transplant Recipients with CMV seropositive donors: an exploratory study from Spanish GETH/TC Centers.

Obert
  • Codi protocol: TORMENT
  • Codi EudraCT: No aplica
  • Servei: Hematologia i Hematoteràpia
  • Investigador/a principal:  Pérez González, Ana
  • Malaltia: Tumors
  • Fase: Fase III